BioStock: PolarCool expands market potential with new investment

PolarCool has announced joining forces with BrainCool's subsidiary CoolPrevent to invest in new, more cost-effective and patentable products for single use that enable the treatment of whiplash injuries but also in the area of ​​rehab. This investment gives PolarCool, which continues to grow its market share through new deals regarding the use of its braincooling device PolarCap, the potential to expand its market even further.

Read the interview with Erik Andersson at biostock.se:

https://www.biostock.se/en/2022/02/polarcool-expands-market-potential-with-new-investment/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se